Repeated ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein thrombus
RusTACE can be safely performed in HCC with PVTT and has a high local control rate.
Authors
- Toshio Kaminou
- Akira Yamamoto (ORCID: https://orcid.org/0000-0002-4567-9745)
- Sawako Uchida‐Kobayashi (ORCID: https://orcid.org/0000-0002-5198-3102)
- Ken Kageyama
- Etsuji Sohgawa (ORCID: https://orcid.org/0000-0002-7213-4740)
- Yukio Miki (ORCID: https://orcid.org/0000-0003-0621-0044)
- Ryuichi Kita
- Atsushi Jogo (ORCID: https://orcid.org/0000-0003-1974-4790)
- Akihiro Tamori (ORCID: https://orcid.org/0000-0001-9119-4864)
- Shigekazu Takemura (ORCID: https://orcid.org/0000-0002-5221-7258)
Institutions
- Yazaki (United States) (US)
- Osaka City University (JP)
- Universidad Metropolitana (VE)
- Osaka Red Cross Hospital (JP)
- Kashiwa Municipal Hospital (JP)
- Osaka Metropolitan University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- British Journal of Radiology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1093/bjr/tqaf112
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00